Lv51
918 积分 2023-04-23 加入
Phase 1/1b Safety Study of Prgn-3006 Ultracar-T in Patients with Relapsed or Refractory CD33-Positive Acute Myeloid Leukemia and Higher Risk Myelodysplastic Syndromes
1小时前
待确认
Interleukin-15-armoured GPC3 CAR T cells for patients with solid cancers
4天前
已完结
Resolving inter- and intra-patient heterogeneity inNPM1-mutated AML at single-cell resolution
12天前
已完结
Pan-carcinoma sialyl-Tn-targeting expands CAR therapy to solid tumors
12天前
已完结
Preclinical evaluation of antitumor activity and toxicity of TROP2-specific CAR-T cells for treatment of triple-negative breast cancer
12天前
已完结
CDK4/6 Inhibitor Priming Enhances PD‐1 Blockade via Sellhi Neutrophil‐Induced Stat5a+ Progenitor Exhausted CD8+ T Cell
12天前
已完结
CD33KO-CD33-mesothelin Loop CAR design avoids fratricide and improves efficacy of iNK cells against acute myeloid leukemia
12天前
已完结
Unveiling the role of c-Met: A promising target for cardiovascular disease
12天前
已关闭
Cell adhesion molecule ITGB2 promotes CAR-T cell therapy in B-cell malignancies
12天前
已关闭
Targeting CD117 on hematopoietic stem and progenitor cells impairs CAR T cell activity
12天前
已关闭
皖公网安备34019202002308
